Alexander Edward Perl, MD, MS is a member of the leukemia program in the Abramson Cancer Center of the University of Pennsylvania and an Associate Professor of Medicine at the Perelman School of Medicine.
Alexander E. Perl, MD, MS, an associate professor in the leukemia program at the Abrams Cancer Center, University of Pennsylvania, recently presented at a conference. He discussed identifying resistance mechanisms in FLT3 mutated AML patients and shared data-driven strategies for improved treatment.
REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
The conference featured leading physicians engaging in insightful discussions about current research trends and innovative approaches. Q&A sessions added depth to the presentations, fostering a collaborative atmosphere. He privileged to contribute to this esteemed community’s efforts in advancing medical research and patient care.